Qual é o preço para HeraMED Limited (HMD)

O preço para HeraMED Limited (HMD) é $0.02609554

Qual é a capitalização de mercado para HeraMED Limited (HMD)

A capitalização de mercado para HeraMED Limited (HMD) é $30.24M

HeraMED Limited (HMD) LPA

HeraMED Limited and its associated entities are dedicated to the design, production, and sale of at-home fetal heart rate monitors and comprehensive pregnancy monitoring systems. These solutions are offered to consumers throughout Australia, Europe, and Israel. Key products include HeraBEAT, a device enabling expectant mothers to personally track their baby's heartbeat, and HeraCARE, a sophisticated digital platform facilitating the creation and deployment of health solutions for effective maternity care management. The company is also at the forefront of developing EchoBEAT, envisioned as the subsequent evolution of its domestic pregnancy monitoring tools, alongside Orion, an artificial intelligence-driven system engineered for profound pregnancy monitoring analysis. A strategic partnership with Mayo Clinic supports the ongoing advancement of the HeraCARE pregnancy management platform. Established in 2011, HeraMED Limited operates from its main office in Netanya, Israel.

Ano	EPS	Alterar
Não há dados suficientes para as datas fornecidas.

Ano

EPS

Alterar

Não há dados suficientes para as datas fornecidas.

Empresa	EPS	Diferença de EPS	País
Abbott Laboratories ABT.US	$3.11	-	US
Stryker Corporation SYK.US	$9.73	-	US
Medtronic plc MDT.US	$3.59	-	IE
Boston Scientific Corporation BSX.US	$2.48	-	US
Edwards Lifesciences Corporation EW.US	$1.74	-	US

Empresa

EPS

Diferença de EPS

País